Form 4: Crawford & Co Director to Acquire 11,111 Shares
Insider Transaction Report
A Crawford & Company director is set to acquire 11,111 shares of Class A Common Stock at no cost under a pre-arranged 10b5-1 plan.
Summary
- Lisa G. Hannusch, a Director of Crawford & Company, is scheduled to acquire 11,111 shares of Class A Common Stock.
- The transaction is planned for February 9, 2026, and was filed on February 10, 2026.
- The shares will be acquired at a price of $0, indicating a grant or award rather than an open market purchase.
- This acquisition is being made pursuant to a Rule 10b5-1(c) plan, which allows insiders to set up a pre-arranged plan for buying or selling securities.
- Following this transaction, Ms. Hannusch will beneficially own a total of 83,802 shares of Class A Common Stock directly.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as moderately positive. While not an open market purchase, the increase in director ownership through a scheduled grant under a 10b5-1 plan aligns insider interests with shareholders.
Positives
- The planned acquisition increases Director Lisa G. Hannusch's beneficial ownership in Crawford & Company, further aligning her interests with those of shareholders.
- The transaction is part of a pre-arranged 10b5-1 plan, demonstrating a structured approach to insider equity management.
Negatives
- The acquisition is a grant at a $0 price, not an open market purchase, which typically signals a stronger vote of confidence from an insider using their own capital.
Future Outlook
The filing does not contain forward-looking statements or guidance beyond the scheduled transaction date.
Industry Context
StockSavvy.ai notes that insider transactions, particularly acquisitions, are often viewed by the market as a signal of management's confidence in the company's future prospects. While this is a scheduled grant rather than an open market purchase, it still represents an increase in director ownership, which can be a positive indicator for investors in the insurance services and claims management industry.
Comparison to Industry Standards
- This specific transaction is an individual director's equity grant and is not directly comparable to industry-wide financial performance benchmarks or project results.
- However, the use of a 10b5-1 plan for equity grants is a common practice across publicly traded companies, including those in the insurance and financial services sectors, to manage insider trading compliance.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Plan Disclosure | The transaction is made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). | 02/09/2026 | Enhances transparency regarding insider trading activities and provides an affirmative defense against insider trading allegations for pre-planned transactions. |
Related Party Transactions
- This is an insider transaction where a director is acquiring shares from the company, likely as part of a compensation package or equity award.
Stakeholder Impact
- Shareholders: Increased director ownership can be seen as a positive signal, potentially boosting investor confidence due to better alignment of interests.
- Employees: The grant of shares to a director may reflect a broader compensation strategy that includes equity incentives for key personnel.
Key Dates
| Date | Description |
|---|---|
| 02/09/2026 | Date of planned acquisition of Class A Common Stock by Lisa G. Hannusch. |
| 02/10/2026 | Date the Form 4 filing was signed and submitted. |
Recommendation
holdThe acquisition of shares by a director, even if a grant, generally signals confidence and aligns management interests with shareholders. However, as it's not an open market purchase and the transaction date is in the future, it doesn't warrant a 'buy' recommendation based solely on this filing. It supports a 'hold' position, indicating stability and insider commitment.
Keywords
Crawford & Company, CRDA, CRDB, Insider Transaction, Form 4, Director Stock Acquisition, 10b5-1 Plan, Equity Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.